Health Care & Life Sciences » Pharmaceuticals | Shenzhen Hepalink Pharmaceutical Co. Ltd.

Shenzhen Hepalink Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,496
1,948
2,273
2,237
2,654
4,794
Cost of Goods Sold (COGS) incl. D&A
1,153
1,413
1,474
1,600
2,095
2,979
Gross Income
343
534
799
637
559
1,815
SG&A Expense
189
291
351
380
414
779
EBIT
148
223
415
231
107
995
Unusual Expense
-
-
4
10
7
16
Non Operating Income/Expense
5
6
34
208
14
181
Interest Expense
-
38
87
107
168
227
Pretax Income
379
397
691
479
24
1,055
Income Tax
66
61
122
89
114
139
Equity in Affiliates
-
-
-
4
19
324
Consolidated Net Income
313
335
568
386
118
592
Net Income
317
338
580
397
131
616
Net Income After Extraordinaries
317
338
580
397
131
616
Net Income Available to Common
317
338
580
397
131
616
EPS (Basic)
0.25
0.26
0.45
0.32
0.11
0.49
Basic Shares Outstanding
1,280
1,280
1,280
1,247
1,247
1,247
EPS (Diluted)
0.25
0.26
0.45
0.32
0.11
0.49
Diluted Shares Outstanding
1,280
1,280
1,280
1,247
1,247
1,247
EBITDA
174
257
519
401
272
1,223
Other Operating Expense
6
21
33
27
38
41
Non-Operating Interest Income
231
212
287
132
106
86
Minority Interest Expense
4
3
12
11
13
24

About Shenzhen Hepalink Pharmaceutical Co.

View Profile
Address
No. 21 Langshan Road
Shenzhen Guangdong 518057
China
Employees -
Website http://www.hepalink.com
Updated 07/08/2019
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is engaged in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products, including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.